ApyraMed - Model MV-003 - Antibiotic-induced Dysbiosis

Antibiotic-induced dysbiosis exposes the organism to various medical conditions. The intestinal mucosal surface is inhabited by a complex commensal microbiota that ensures intestinal homeostasis and organism’s physiologic functions. Antibiotic treatments can severely affect microbiota diversity and cause dysbiosis, thereby exposing the host to pathophysiological consequences, including intestinal inflammation, susceptibility to enteric infections, metabolic alterations and a number of systemic effects. ApyraMed promotes microbiome recovery and selection of beneficial bacteria after antibiotic treatment. This results in powerful control of antibiotic-induced enteric infections and metabolic alterations.